Navigation Links
Role of hormones, potential new treatments topic of UH lecture
Date:9/7/2012

While estrogen is essential for many of the body's normal processes in both men and women, it also plays a role in diseases such as breast, ovarian and prostate cancer. The impact of this hormone on such diseases will be addressed during a lecture Sept. 25 at the University of Houston (UH).

Dr. Jan-ke Gustafsson, biochemistry professor and director of the Center for Nuclear Receptors and Cell Signaling at UH, will present "Hormones in Health and Disease." He will be the third speaker in a UH lecture series highlighting the impact of science on health and society.

The lecture will focus on the discovery and functions of estrogen receptor beta (ERbeta) and its impact on drug delivery and disease. A steroid hormone found in both males and females, estrogen binds to and activates the estrogen receptors, triggering the regulation of gene expression.

In 1995, Gustafsson and his research group discovered there are two estrogen receptors instead of one. The discovery of ERbeta was a major and unexpected breakthrough. He is now proving the theories arising from that initial discovery. Due to its broad influence in the human body, ERbeta is a premier target for drug delivery and therapies.

"Estrogen and estrogen receptors are found in tissues ranging from the central nervous system, to breast tissue and the cardiovascular system," Gustafsson said. "ERbeta also regulates functions in the ovary, testis, prostate, kidney, bone and colon. Today, researchers are exploring the receptor as a target for drugs in treatments of neurological diseases, psychological disorders and cancer."

Sponsored by the College of Natural Sciences and Mathematics (NSM), the Friends of NSM Distinguished Lecture Series features leading scientists and physicians addressing breakthroughs in science that will alter the prevention, diagnosis and treatment of diseases, as well as impact the delivery of medical care. The lectures are free and open to the public.

WHO:

Jan-ke Gustafsson, M.D., Ph.D.

Robert A. Welch Professor of Chemistry

Director, Center for Nuclear Receptors and Cell Signaling at UH

WHAT:

Lecture: "Hormones in Health and Disease"

Friends of NSM Distinguished Lecture Series: Science Impacting Health and Society

WHEN:

7 8 p.m., Tuesday, Sept. 25

WHERE:

University of Houston
Rockwell Pavilion, second floor of the UH M.D. Anderson Library
Off Calhoun Road, Entrance 1
Map: http://www.friends.nsm.uh.edu/directions


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related medicine news :

1. PharmaNet system dramatically reduced inappropriate prescriptions of potentially addictive drugs
2. Cleveland Clinic researchers investigating potential drug for treatment of Alzheimers disease
3. US performs worst on potentially preventable death rates compared to France, Germany, and the UK
4. Could a cancer drug potentially prevent learning disabilities in some kids?
5. Earphones potentially as dangerous as noise from jet engines, according to new study
6. Diagnostic test shows potential to noninvasively identify significant coronary artery disease
7. CSI technology holds potential in everyday medicine
8. Potential new treatment target identified for melanoma skin cancer
9. Potential Nipah vaccine passes primate test
10. Researchers find potential cancer roadblock
11. Early treatment could mean greater earning potential for people with HIV
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Role of hormones, potential new treatments topic of UH lecture
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier ... position. The former overall number one pick in the 2001 NFL Draft, to the ... the record for the most career rushing yards by a quarterback (6,109) and the ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin ... of Education Research Award. The award honors scholars exemplary in their capacity to ... scholar who has demonstrated the capacity to deepen the public’s understanding and appreciation ...
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... that they are seeking public support to bring their novel lifesaving device for ... wearable device packed with medical-grade sensors, specially designed to read a child’s vital ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
(Date:4/18/2017)... 2017 Research and Markets has announced ... Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... revenues as well as growth in the number of unit ... to market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology: